Director/PDMR Shareholding
2010年5月27日 - 11:16PM
RNSを含む英国規制内ニュース (英語)
TIDMLPX
RNS Number : 6705M
Lipoxen PLC
27 May 2010
+---------------------------------+---------------------------------+
| For immediate release | 27 May 2010 |
+---------------------------------+---------------------------------+
Lipoxen plc
("Lipoxen" or the "Company")
Director dealings
The Company was informed on 27 May 2010 that FDS Pharma Associates and its
related parties disposed of 190,266 ordinary shares of 0.5p each ("Ordinary
Shares") at 9.78 pence each on 29 December 2009.
Following these disposals FDS Pharma Associates and its related parties have an
interest in Lipoxen of 41,965,050 Ordinary Shares, representing 24.41 per cent
of the issued Ordinary Share capital in the Company.
Enquires:
+------------------------------------------+--------------------+
| Lipoxen plc | +44 (0)20 7389 |
| | 5015 |
+------------------------------------------+--------------------+
| M. Scott Maguire, Chief Executive | |
| Officer | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Singer Capital Markets (nominated | +44 (0)20 3205 |
| adviser) | 7500 |
+------------------------------------------+--------------------+
| Jeff Keating / Claes Spång | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Buchanan Communications | +44 (0)20 7466 |
| | 5000 |
+------------------------------------------+--------------------+
| Lisa Baderoon / Catherine Breen | |
+------------------------------------------+--------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSGMGZKDNLGGZM
Lipoxen (LSE:LPX)
過去 株価チャート
から 5 2024 まで 6 2024
Lipoxen (LSE:LPX)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Lipoxen (ロンドン証券取引所): 0 recent articles
その他のLipoxenニュース記事